Collection 報告 [0/1] 專利 [0/11] 期刊論文 [193/194] 會議論文/會議摘要 [41/48] Siblings 于重元 [19/19] 劉柯俊 [85/98] 劉滄梧 [119/125] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 姜乃榕 [82/94] 常慧如 [39/44] 張光裕 [69/79] 張憶壽 [103/106] 張文祥 [52/53] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/43] 李家惠 [29/29] 李岳倫 [48/49] 林素芳 [32/32] 楊奕馨 [41/42] 江士昇 [88/90] 沈哲宏 [14/16] 洪文俊 [88/88] 莊雙恩 [82/91] 蔡坤志 [32/34] 蔡慧珍 [66/71] 蘇勇曄 [40/40] 蘇振良 [24/25] 郭靜娟 [71/76] 陳尚鴻 [45/48] 陳振陽 [72/72] 陳立宗 [443/510] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [38/39] 黃智興 [55/55] 黃道揚 [26/26] 丁兆治(2000-2004) [5/5] 其他 [464/471] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/55] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] Community Statistics 近3年內發表的文件:0(0.00%) 含全文筆數:234(92.13%) 文件下載次數統計 下載大於0次:234(100.00%) 下載大於100次:234(100.00%) 檔案下載總次數:146965(2.74%) 最後更新時間: 2024-12-01 08:22 Top Upload Loading... Top Download Loading... Recent Submissions Identification of prognostic biomar... A novel NRF2/ARE inhibitor gossypol... Targeting lysosomal cysteine protea... c-MYC-directed NRF2 drives malignan... Ephrin A4-ephrin receptor A10 signa... Phase I dose-escalation study of SC... Germline susceptibility variants im... Index of cancer-associated fibrobla... The SMAC mimetic LCL161 is a direct... The tumor suppressor TGFBR3 blocks ...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 126-150 of 254. (11 Page(s) Totally) << < 1 2 3 4 5 6 7 8 9 10 > >> View [10|25|50] records per page

Date	Title	Relation
2012-03-06	Indole compounds	CA2437104/2012-03-06
2012-03	Modulation of chemotactic and pro-inflammatory activities of endothelial progenitor cells by hepatocellular carcinoma	Cellular Signalling. 2012 Mar;24(3):779-793.
2012-02	Phase I study of biweekly liposome irinotecan (PEP02, MM-398) in metastatic colorectal cancer failed on firstline oxaliplatin-based chemotherapy	Journal of Clinical Oncology. 2012 Feb;30(4):613.
2012-01	Differences in the frequencies of K-ras c12-13 genotypes by gender and pathologic phenotypes in colorectal tumors measured using the allele discrimination method	Environmental and Molecular Mutagenesis. 2012 Jan;53(1):22-31.
2011-12-22	5-Amino-2-aroylquinolines as highly potent tubulin polymerization inhibitors. Part 2. The impact of bridging groups at position C-2	Journal of Medicinal Chemistry. 2011 Dec 22;54(24):8517-8525.
2011-12-15	Combination of arsenic trioxide and BCNU synergistically triggers redox-mediated autophagic cell death in human solid tumors	Free Radical Biology and Medicine. 2011 Dec 15;51(12):2195-2209.
2011-12	Induction chemotherapy with gemcitabine, oxaliplatin, and 5-Fluorouracil/Leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study	International Journal of Radiation Oncology, Biology, Physics. 2011 Dec;81(5):e749-e757.
2011-11-15	Novel phosphoinositide 3-kinase/mTOR dual inhibitor, NVP-BGT226, displays potent growth-inhibitory activity against human head and neck cancer cells in vitro and in vivo	Clinical Cancer Research. 2011 Nov 15;17(22):7116-7126.
2011-11-15	Coumarin compounds and their use for treating cancer	US8058427B2/2011-11-15
2011-10-01	Enhancement of non-homologous end joining DNA repair capacity confers cancer cells resistance to the novel selenophene compound, D-501036	Cancer Letters. 2011 Oct 1;309(1):110-118.
2011-10	Novel terpenoids from calocedrus macrolepis var. formosana	Chemistry and Biodiversity. 2011 Oct;8(10):1901-1907.
2011-09-23	BPR1K653, a novel Aurora Kinase Inhibitor, exhibits potent anti-proliferative activity in P-gp170 (MDR1)-mediated VX680-resistant cancer cells in vitro and in vivo	European Journal of Cancer. 2011 Sep 23;47:S127.
2011-09-23	A phase II study of neoadjuvant bio-chemotherapy with Cetuximab, Paclitaxel, and Cisplatin (CPC) followed by Cetuximab-based concurrent bio-radiotherapy in high-risk locally advanced head and neck cancer - representative of head and neck cancer study grou	European Journal of Cancer. 2011 Sep 23;47:S547-S548.
2011-09	Synthesis and biological evaluation of 1-(4′-Indolyl and 6′-Quinolinyl) indoles as a new class of potent anticancer agents	European Journal of Medicinal Chemistry. 2011 Sep;46(9):3623-3629.
2011-09	DNA repair enzyme, O6-methylguanine DNa methyltransferase, modulates therapeutic efficacy of platinum drugs with radiation and its clinical significance	European Journal of Cancer. 2011 Sep;47:S132.
2011-08	Identification of salt-inducible kinase 3 as a novel tumor antigen associated with tumorigenesis of ovarian cancer	Oncogene. 2011 Aug;30(33):3570-3584.
2011-08	BPR1K653, a novel aurora kinase inhibitor, exhibits potent anti-proliferative activity in MDR1 (P-gp170)-mediated multidrug-resistant cancer cells	PLoS ONE. 2011 Aug;6(8):Article number e23485.
2011-07	MicroRNA signature and aberrant methylation in human oral squamous cell carcinomas	Oral Oncology. 2011 Jul;47(Suppl. 1):S92.
2011-06	Antimutagenic constituents of adlay ( Coix lachryma-jobi L. var. ma-yuen Stapf) with potential cancer chemopreventive activity	Journal of Agricultural and Food Chemistry. 2011 Jun;59(12):6444-6452.
2011-06	Aurora kinase inhibitor patents and agents in clinical testing: an update (2009-10)	Expert Opinion on Therapeutic Patents. 2011 Jun;21(6):857-884.
2011-05	Pharmacokinetic study with novel anticanacer agents, MPTOB124 and MPTOB214	Drug Metabolism Reviews. 2011 May;43(Suppl. 1):73.
2011-04-28	Scaffold-hopping strategy: Synthesis and biological evaluation of 5,6-Fused bicyclic heteroaromatics to identify orally bioavailable anticancer agents	Journal of Medicinal Chemistry. 2011 Apr 28;54(8):3076-3080.
2011-04-06	Indole compounds as inhibitors of tubulin polymerisation for the treatment of angiogenesis related disorders	EP1506960/2011-04-06
2011-04	Concise syntheses of N-aryl-5,6,7-trimethoxyindoles as antimitotic and vascular disrupting agents: application of the copper-mediated Ullmann-type arylation	Organic and Biomolecular Chemistry. 2011 Apr;9(9):3154-3157.
2011-04	Activation of Akt/FoxO axis confers resistance to cisplatin in human nasopharyngeal carcinomas	Cancer Research. 2011 Apr;71:Abstract number 1701.

Showing items 126-150 of 254. (11 Page(s) Totally) << < 1 2 3 4 5 6 7 8 9 10 > >> View [10|25|50] records per page